We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Blog

Determining Prognostic Significance of Biomarkers for Risk Stratification of Early Stage Lung Cancer

Determining Prognostic Significance of Biomarkers for Risk Stratification of Early Stage Lung Cancer

Blog

During this year’s AACR Annual Meeting we spoke to Dr. Delphine Lissa and Dr. Ana Robles from the National Cancer Institute to learn more about the team’s most recent study on the use of two specific biomarkers for risk stratification of stage I lung cancer patients.

Read More

Digital Pathology Solution Could Speed Up Prostate Cancer Diagnosis

Digital Pathology Solution Could Speed Up Prostate Cancer Diagnosis

Blog

To learn more about ContextVision, their move into the field of digital pathology, and how INIFY™ could help benefit pathologists and patients, we spoke to Lena Kajland Wilén, Director Business Unit Digital Pathology.

Read More

The STING Pathway and Cancer

The STING Pathway and Cancer

Blog

STING (stimulator of interferon genes) is a key mediator of innate immunity and the STING pathway has been shown to be involved in the induction of an anti-tumor immune response. We recently spoke to Andrea van Elsas, PhD, Chief Scientific Officer at Aduro Biotech to learn more about the company’s expertise in STING Pathway Activator technology.

Read More

HPV-Positive Oropharyngeal Cancers: Predicting Treatment Response Using ddPCR

HPV-Positive Oropharyngeal Cancers: Predicting Treatment Response Using ddPCR

Blog

During this year’s AACR Annual Meeting we spoke to Julianna Supplee, Research Technician at the Robert and Renée Belfer Center for Applied Cancer Science at Dana-Farber Cancer Institute, to learn more about the team’s most recent study on the use of plasma HPV cell-free DNA as an early predictor of treatment response in patients with advanced oropharyngeal cancer.

Read More

Using Cell-free DNA as a Marker for Liver Cancer Diagnosis

Using Cell-free DNA as a Marker for Liver Cancer Diagnosis

Blog

During this year’s AACR conference we spoke to Kang Zhang, M.D., Ph.D. from the University of California, San Diego about the collaborative work he has been doing with the Laboratory for Advanced Medicine. He discusses their recent study findings on the use of a blood-based method to look at cell-free DNA as a marker for liver cancer diagnosis and prognosis.

Read More

Genomic Profiling in Cancer: Matching Patients to Precision Trials, Guiding Patients to the Right Treatment

Genomic Profiling in Cancer: Matching Patients to Precision Trials, Guiding Patients to the Right Treatment

Blog

We recently spoke to Gaurav Singal, Vice President of Data Strategy and Product Development at Foundation Medicine, to learn more about how their SmartTrialsTM technology platform has enabled patients to be rapidly matched to precision trials, based on their unique tumor biomarkers.

Read More

Accelerating the Development of Organs-on-Chips

Accelerating the Development of Organs-on-Chips

Blog

Emulate, Inc. and AstraZeneca recently announced they have formed a collaborative partnership which will see Emulate's Organs-on-Chips technology embedded in AstraZeneca's Innovative Medicines and Early Development Biotech Unit.

Read More

Deploying Cloud Technologies to Fight Pediatric Cancer

Deploying Cloud Technologies to Fight Pediatric Cancer

Blog

The St. Jude Cloud is a recently-launched online data-sharing and collaboration platform that provides access to the largest public repository of pediatric cancer genomics data. We caught up with Jinghui Zhang, PhD, from St. Jude Children’s Research Hospital to discuss the cloud and its impact on pediatric research.

Read More

Newly Discovered Biomarker Could Help Diagnose Hearing Loss Earlier

Newly Discovered Biomarker Could Help Diagnose Hearing Loss Earlier

Blog

In collaboration with UConn, Sensorion have identified the first potential biomarker for noise-induced hearing loss, findings which were recently presented at the 53rd American Neurotology Society Annual Spring Meeting.

Read More

Next Generation Sequencing for the Masses?

Next Generation Sequencing for the Masses?

Blog

Thermo Fisher Scientific’s Oncomine Dx Target Test, a cancer diagnostics panel, is set to be made available to 160 million people in the US through both Medicare and Medicaid and private insurers. We spoke with Joydeep Goswami, president of Clinical NGS and Oncology for Thermo Fisher Scientific, about the progress of NGS tests in the clinic.

Read More